At the news
? MIXEDIMPACT 6/10 8-K filed Apr 9, 2026 at 07:00 ET
Treace Medical Concepts issued a preliminary Q1 2026 outlook showing revenue of $47.0–47.2M and cash rising to $51.9M, while updating full-year 2026 revenue guidance to $202–212M. The Chief Commercial Officer departed and will transition to a consulting role, with responsibilities absorbed internally.
- Preliminary Q1 2026 revenue: $47.0–47.2 million
- Cash, cash equivalents, and marketable securities expected to be ~$51.9 million as of March 31, 2026, up from $48.4 million at year-end
- Updated full-year 2026 revenue guidance raised to $202–212 million (from $200–212 million)
- Chief Commercial Officer Gaetano Guglielmino departed; no replacement planned; responsibilities reassigned
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access